期刊文献+

贝莱斯芽孢杆菌抗真菌能力及基因组分析 被引量:4

Antifungal activity and genomic analysis of Bacillus velezensis X49
原文传递
导出
摘要 蛋白水解酶及脂肽类化合物具有广谱的抑菌活性,这些抑菌活性蛋白及物质拥有巨大的研究和开发潜力。本研究通过蛋白水解酶平板筛选到一株对6种不同病原真菌有较明显抑菌效果的菌株,命名为X49,对该菌株进行理化分析,并由16S rRNA基因测序、API测试和电镜分析鉴定菌种,进一步分析其基因组序列,再利用偶氮酪蛋白方法分析蛋白水解酶活性及提取脂肽类化合物进行抗真菌测试。结果表明,该菌株在10–50℃、pH 4.0–9.0范围内均可以生长,对环境盐浓度的适应性较强,在10%NaCl浓度下仍然能够生长。菌种鉴定发现X49菌株属于贝莱斯芽孢杆菌(Bacillus velezensis)。基因组分析则显示,B. velezensis X49菌株有11个编码的丝氨酸蛋白酶,其基因编号1_894属于S8枯草杆菌蛋白酶家族,与已知具有抗真菌能力的丝氨酸蛋白酶有高达99%的相似度。另外有多达30个编码的非核糖体肽合成酶,其中包含参与合成已知的表面活性素、伊枯草菌素、丰原素、杆菌肽及短杆菌肽脂肽类化合物。胞外蛋白水解酶活性分析发现其在高温下仍具有一定的活性。将B. velezensis X49菌株与中药干姜共发酵后,提取出的脂肽类化合物,其抑菌功效大大提高。由此可见,本研究筛选出的B. velezensis X49菌株对于植物及人类病原菌都有很显著的抑制作用。而与中药共发酵的活性物质可作为未来药物的研究开发。 Proteolytic enzymes and lipopeptides contain broad-spectrum antimicrobial activities, which have great potential for research and development. A microbial strain X49 obtained from protease screening plate showed antifungal activities against six fungi. Biochemical analysis, 16S rRNA sequencing, API identification system, and electron microscope analysis were carried out to identify the bacterium. Azocasein method was used to analyze the protease activity. Lipopeptides were extracted for antifungal analysis. The result indicated that strain X49 grew in the range of 10–50 °C and pH 4.0–9.0.Moreover, it survived in 10% NaCl, showing good halotolerance. Strain X49 was identified as Bacillus velezensis. Genomic analysis of B. velezensis X49 revealed eleven genes encoding serine protease. The ID 1_894 belonging to S8 subtilisin family was 99% similar to the serine protease with known antifungal ability. On the other hand, thirty genes encoding non-ribosomal peptide synthetase involved in the lipopeptide biosynthesis, including surfactin, iturin, fengycin, bacitracin, and gramicidin, were identified. Part of the extracellular proteolytic activity remained under high temperature. After co-fermentation of B. velezensis X49 with Zingiber officinale Rosc., the antifungal activity of the lipopeptide extract from the co-fermentation was greatly improved. In conclusion, B. velezensis X49showed clear inhibitory effect on both plant and human pathogens. The active substances co-fermented with Chinese herbs and microbes can be utilized for further drug development.
作者 陈芳芳 余小妹 韩晶晶 吴春 庞海月 张书迪 陈煜沛 CHEN Fangfang;YU Xiaomei;HANG Jingjing;WU Chun;PANG Haiyue;ZHANG Shudi;CHEN Yupei(Department of Public Health and Medical Technology,Xiamen Medical College,Xiamen 361023,Fujian,China;Engineering Research Center of Natural Cosmeceuticals College of Fujian Province,Xiamen 361023,Fujian,China;Department of Pharmacy,Xiamen Medical College,Xiamen 361023,Fujian,China;Department of Clinical Medicine,Xiamen Medical College,Xiamen 361023,Fujian,China;Institute of Respiratory Diseases,Xiamen Medical College,Xiamen 361023,Fujian,China)
出处 《生物工程学报》 CAS CSCD 北大核心 2022年第6期2292-2307,共16页 Chinese Journal of Biotechnology
基金 福建省卫生健康科技计划项目(2019-ZQNB-20,2019-ZQNB-23)。
关键词 真菌 非核糖体肽合成酶 蛋白酶 丝氨酸蛋白酶 芽孢杆菌 干姜 fungal non-ribosomal peptide synthase protease serine protease Bacillus Zingiber
  • 相关文献

参考文献4

二级参考文献49

  • 1张明发 范荣培 等.温里药镇痛作用研究[J].陕西中医,1989,10(5):231-231.
  • 2池田正树.生姜的药理学研究(第1报)-辣味成分(6)-姜酚、(6)-姜烯酚的一般药理作用[J].国外医学:中医中药分册,1981,(2):117-118.
  • 3末川守.关于生姜药理学的研究(第Ⅳ报)-6-姜醇对于花生四烯酸代谢的作用[J].国外医学:中医中药分册,1987,9(3):160-162.
  • 4微生物研究法讨论会.微生物学实验法[M].北京:科学出版社,1981.155-156.
  • 5徐叔云 等.药理实验方法学:第2版[M].人民卫生出版社,1994.1275.
  • 6Chen L, Wang N, Wang X, et al. Characterization of two anti- fungal lipopeptides produced by Bacillus amyloliquefaciens SH- BIO[J]. Bioresour. Technol,2010, 101(22):8822-8827.
  • 7Vilela WF, Fonseca SG, Fantinatti-Garboggini F, et al. Produc- tion and Properties of a Surface-Active Lipopeptide Produced by a New Marine Brevibacterium luteolum Strain [ J ]. Applied bio- chemistry and biotechnology,2014, 174 ( 6 ) : 2245-2256.
  • 8Sharafi H, Abdoli M, Hajfarajollah H, et al. First report of a li-popeptide biosurfactant from thermophilic bacterium Aneuriniba- cillus thermoaerophilus MKO1 newly isolated from municipal landfill site [ J ]. Applied biochemistry and biotechnology, 2014, 173(5): 1236-1249.
  • 9Baltz R, Miao V, Wrigley S. Natural products to drugs: dapto- mycin and related lipopeptide antibiotics [ J]. Nat ProdRep, 2005, 22(6) : 717-741.
  • 10Pirri G, Giuliani S, Nicoletto S, et al. Lipopeptides as anti-in- fectives : a practical perspective [ J ]. Central European Journal of Biology, 2009, 4 (3) : 258-273.

共引文献130

同被引文献97

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部